; (C) identify any policy, resource, capability, or other gaps in the Department’s ability to assess, prevent, protect against, and respond to biological threats; and (D) identify any organizational changes or reforms necessary for the Department to effectively execute its biodefense mission and role, including with respect to public and private partners in the biodefense enterprise. (3) Strategy Not later than 1 year after completion of the review required under paragraph (1), the Secretary shall issue a biodefense strategy for the Department that— (A) is informed by such review and is aligned with section 1086 of the National Defense Authorization Act for Fiscal Year 2017 ( 6 U.S.C. 104 ; relating to the development of a national biodefense strategy and associated implementation plan, including a review and assessment of biodefense policies, practices, programs, and initiatives) or any successor strategy; and (B) shall— (i) describe the biodefense mission and role of the Department, as well as how such mission and role relates to the biodefense lines of effort of the Department; (ii) clarify, as necessary, biodefense roles, responsibilities, and capabilities of the components and offices of the Department involved in the biodefense lines of effort of the Department; (iii) establish how biodefense lines of effort of the Department are to be coordinated within the Department; (iv) establish how the Department engages with public and private partners in the biodefense enterprise, including other Federal agencies, national laboratories and sites, and State, local, and Tribal entities, with specificity regarding the frequency and nature of such engagement by Department components and offices with State, local, and Tribal entities; and (v) include information relating to— (I) milestones and performance metrics that are specific to the biodefense mission and role of the Department described in clause (i)